Investor profile

Alexandria Venture Investments

Strategic venture capital platform of Alexandria Real Estate Equities, investing in life science companies. Investor in IMMvention Therapeutix (Durham) and Hoofprint Biome (Raleigh).

Corporate investor

Pasadena, CA

Visit website

Directory portfolio

Companies connected here

Latest company funding first, including rounds involving other investors. Unknown dates last.

I
IMMvention Therapeutix
Latest company funding · Dec 23, 2022
Preclinical biotech developing oral small-molecule BACH1 inhibitors for sickle cell disease and other chronic conditions, with its systemic program licensed to Novo Nordisk.

Portfolio coverage reflects public company-investor links tracked in this directory and may not represent the investor's full portfolio.